NCT03083405View on ClinicalTrials.gov

Selected Disorders and Sleep Bruxism

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sleep BruxismHypertensionThyroid DysfunctionMental Status ChangeSleep ApneaSleep DisordersCardiovascular Risk FactorCardiovascular DiseasesTemporomandibular Disorder
Interventions
DRUG

Opipramol

The study group will get a drug to decrease bruxism activity. Group will be evaluated using polysomnography included rhythmic masticatory muscle activity registration before and after intervention.

Trial Locations (1)

Unknown

Wroclaw Medical University, Wroclaw

All Listed Sponsors
lead

Wroclaw Medical University

OTHER